Trost B N
Medizinische Universitätspoliklinik, Inselspital, Bern, Switzerland.
Drugs. 1989 Oct;38(4):621-33. doi: 10.2165/00003495-198938040-00008.
Understanding of the pathophysiology of hypertension and diabetes mellitus and their association is at present fragmentary at best. Optimal antihypertensive drug therapy of patients with both disorders is therefore based on limited experimental data, practical experience and educated guesswork, and needs to be tailored to each (often multimorbid) individual. In most patients monotherapy would be preferred, and would begin with a calcium antagonist or a converting enzyme inhibitor at a low to moderate dosage. If this is not effective an alpha 1-adrenoceptor inhibitor, a cardioselective beta-blocker or a diuretic, always at a low to moderate dosage, should be tried. If still unsuccessful, low dose combinations of 2 of these drugs are next. The (long term) regimen should be as simple as possible, and its effects--desired and undesired--monitored as closely as the carbohydrate disorder.
目前,对于高血压和糖尿病的病理生理学及其关联的理解充其量只是支离破碎的。因此,对患有这两种疾病的患者进行最佳抗高血压药物治疗是基于有限的实验数据、实践经验和经验性猜测,并且需要针对每个(通常患有多种疾病的)个体进行调整。在大多数患者中,首选单一疗法,开始时使用低至中等剂量的钙拮抗剂或转换酶抑制剂。如果这无效,则应尝试使用α1肾上腺素能受体抑制剂、心脏选择性β受体阻滞剂或利尿剂,剂量始终为低至中等。如果仍然不成功,则接下来尝试这两种药物的低剂量组合。(长期)治疗方案应尽可能简单,并像监测碳水化合物紊乱一样密切监测其(期望和不期望的)效果。